Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Garovoy

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Transplantation|December 1, 1985
A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacyO Salvatierra, J Melzer, D Potter, et al.
Transplantation Proceedings|February 1, 1987
Donor-specific blood transfusions versus cyclosporine--the DST storyO Salvatierra, J Melzer, F Vincenti, et al.
Transplantation Proceedings|June 1, 1988
Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipientsN J Feduska, J S Melzer, W J Amend, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Graft vs. host disease after liver transplantation in humans: a report of four casesJ P Roberts, N L Ascher, J Lake, et al.
Transplantation Proceedings|February 1, 1987
Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?J S Melzer, R M Husing, N J Feduska, et al.
British Journal of Haematology|July 1, 1991
Activation of class I HLA expression by TNF-alpha and gamma-interferon is mediated through protein kinase C-dependent pathway in CML cell linesD Seong, S Sims, E Johnson, et al.
Transplantation Proceedings|February 1, 1989
Successful management of the highly sensitized renal allograft recipientJ S Melzer, R Husing, C Lou, et al.
Transplantation|January 1, 1987
The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipientsJ S Melzer, R M Husing, N J Feduska, et al.
Transplantation Proceedings|June 1, 1988
How to improve results for second renal allograftsJ S Melzer, R M Husing, N J Feduska, et al.
Annals of Internal Medicine|April 1, 1981
Recurrent systemic lupus erythematosus involving renal allograftsW J Amend, F Vincenti, N J Feduska, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Transplantation|December 1, 1985
A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacyO Salvatierra, J Melzer, D Potter, et al.
Transplantation Proceedings|February 1, 1987
Donor-specific blood transfusions versus cyclosporine--the DST storyO Salvatierra, J Melzer, F Vincenti, et al.
Transplantation Proceedings|June 1, 1988
Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipientsN J Feduska, J S Melzer, W J Amend, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Graft vs. host disease after liver transplantation in humans: a report of four casesJ P Roberts, N L Ascher, J Lake, et al.
Transplantation Proceedings|February 1, 1987
Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?J S Melzer, R M Husing, N J Feduska, et al.
British Journal of Haematology|July 1, 1991
Activation of class I HLA expression by TNF-alpha and gamma-interferon is mediated through protein kinase C-dependent pathway in CML cell linesD Seong, S Sims, E Johnson, et al.
Transplantation Proceedings|February 1, 1989
Successful management of the highly sensitized renal allograft recipientJ S Melzer, R Husing, C Lou, et al.
Transplantation|January 1, 1987
The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipientsJ S Melzer, R M Husing, N J Feduska, et al.
Transplantation Proceedings|June 1, 1988
How to improve results for second renal allograftsJ S Melzer, R M Husing, N J Feduska, et al.
Annals of Internal Medicine|April 1, 1981
Recurrent systemic lupus erythematosus involving renal allograftsW J Amend, F Vincenti, N J Feduska, et al.
Pageof 4